Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

Abstract #103805

Bertha Alicia Moseson, MD, MPH¹, Kenneth D. Rosenberg, MD, MPH², Jodi A. Lapidus, PhD³, Nancy Glass, PhD, MSN, MPH⁴, and Alfredo P. Sandoval, MBA, MS². (1) Department of Public Health and Preventive Medicine, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, CB669, Portland, OR 97201, (2) Office of Family Health, Oregon Department of Human Services, 800 NE Oregon Street, Suite 850, Portland, OR 97232, 503-731-4507, ken.d.rosenberg@state.or.us, (3) Department of Public Health and Preventive Medicine, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Mail Code CB669, Campus Services Building 669, Portland, OR 97239, (4) School of Nursing, Oregon Health and Science University, 3455 SE U.S. Veterans Hospital Road, Mail Code SN-5N, Portland, OR 97239

Abstract:

The prevalence of intimate partner violence in pregnancy (IPVP) in the United States is estimated at between 4% and 8% of all pregnancies. Among other things, IPVP is associated with substance abuse, trauma, depression, poor nutrition, and sexually transmitted diseases, all detrimental to the health of the fetus as well as the mother. Because pregnancy is a time of frequent contact with the health care system, it is an ideal time to assess women for intimate partner violence (IPV). This study uses 2001 Oregon PRAMS surveillance data, containing information relating to experiences, attitudes and practices of women surrounding pregnancy. Our study identifies four risk factors that can be used to assess for IPV during pregnancy: inability to pay bills (OR 7.9; 95% CI 1.8, 33.7) partner did not want pregnancy (OR 4.9; 95% CI 1.3, 18.4), being close to someone with an alcohol or drug problem (OR 7.9; 95% CI 2.2, 27.8), and previous pregnancy loss (OR 4.9; 95% CI 1.3, 18.4). Even if the woman denies IPV at the intake encounter, these factors may help to identify women at higher risk for IPV during pregnancy thus enabling clinicians to intervene to interrupt the violence and improve health outcomes for mother and child.

Learning Objectives: At the conclusion of this session, the participant will be able to

• Describe the most significant risk factors for intimate partner violence in pregnancy
• Devlop a tool for screening women for intimate partner violence during their prenatal care.

Keywords: Violence Prevention, Prenatal Interventions

Presenting author's disclosure statement:

I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.